Sarma, A. et al. 2023. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pacific Journal of Cancer Care. 8, 1 (Feb. 2023), 35–42. DOI:https://doi.org/10.31557/apjcc.2023.8.1.35-42.